100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
CVS Health (NYSE:CVS) Chief Financial Officer Thomas Cowhey is preparing to step down, according to a Bloomberg News report citing sources familiar with the matter. The timing of his departure remains uncertain, and no official reason has been disclosed.
Cowhey was named CFO in January 2024 after serving in the role on an interim basis since October 2023. His planned exit comes as CVS undergoes a significant corporate restructuring under new CEO David Joyner, who was appointed last October amid mounting financial pressures and investor concerns.
The healthcare giant has struggled in recent years, missing earnings expectations for the first three quarters of 2024 and ultimately withdrawing its full-year guidance upon Joyner’s appointment. In response, Joyner introduced aggressive cost-cutting measures and appointed a new head of the company’s insurance division to help steer the business through what is being called one of the most challenging times in CVS’s 60-year history.
Despite earlier setbacks, CVS managed to beat Wall Street estimates in its fourth-quarter earnings report released in February and provided an annual forecast that met most analysts’ expectations. However, the company remains under scrutiny as it works to regain investor confidence and improve operational efficiency.
CVS declined to comment on Cowhey’s exit and did not immediately respond to requests from Reuters.
As one of the largest health insurers and pharmacy chains in the U.S., CVS’s leadership changes and financial performance are closely watched by analysts and shareholders alike. Cowhey’s departure signals another chapter in the company’s ongoing turnaround strategy as it navigates a rapidly evolving healthcare landscape.
